Together with these results, we also found that advanced cancer stage and extrathyroidal extension in PTC were associated with significantly lower AR (Figure 2) and E-cadherin expression (Figure S4), providing further evidence to support that insufficiency of the AR signaling may promote EMT by which PTC tumor cells can adapt to promote disease recurrence and progression. The gene discussed is CDH1; the disease is cancer.